Report #2843389

Overview

Sex

Unknown

Age

Age unknown

State

KS

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (2)

Symptom narrative

Inappropriate schedule of DTap series.; Kinrix administered too early in the series; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate schedule of vaccine administered in an unspecified number of patients who received DTPa-IPV (Kinrix) for prophylaxis. On an unknown date, the patient received Kinrix. On an unknown date, an unknown time after receiving Kinrix, the patient experienced inappropriate schedule of vaccine administered (Verbatim: Inappropriate schedule of DTap series.) and inappropriate age at vaccine administration (Verbatim: Kinrix administered too early in the series). The outcome of the inappropriate schedule of vaccine administered and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:28-MAY-2025 A pharmacy director called to inform that for Kinrix. It was administered too early in the series, before it should, which led to inappropriate schedule of vaccine administered and inappropriate age at vaccine administration. There were multiple patients. Reporter mentioned that there were 31 patients, no details about each of the patients were provided, as well as lot numbers. However, healthcare professional agreed to follow-up by Safety team to provide additional details. The Vaccine Administration Facility was same as Primary Reporter.